Phase II Study of Combination Therapy with S-1 and Irinotecan for Advanced Non–Small Cell Lung Cancer: West Japan Thoracic Oncology Group 3505Isamu Okamoto, Kazuhiko Nakagawa, Masaki Miyazaki et al.|Clinical Cancer Research|2008Cited by 26